(S)-(3-Aminopyrrolidin-1-yl)(cyclohexyl)methanone hydrochloride, 95.0%, 1g

Trioctylphosphine, 85.0%, 25ml

4-Bromo-2-chlorotoluene, 99.0%, 100g

N-(3-hydroxy-2-pyridinyl)acetamide, 95.0%, 5g

1,2-Bis(2,4-dimethyl-5-phenyl-3-thienyl)-3,3,4,4,5,5-hexafluoro-1-cyclopentene>98.0%(HPLC)1g

ethyl 7-amino[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate, 1g

5-Fluoro-3-methyl-2-nitrobenzoic acid, 97%, 5g

Tetrakis(trifenilfosfina)paladio(0), mínimo 98 %, 10 g, envase de vidrio

(2S)-2-(4-(3-Amino-1,9-dioxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl)benzamido)pentanedioic acid, 95%, 5mg

[(9H-Fluoren-9-ylmethoxycarbonyl)-phenyl-amino]-acetic acid, 95.0%, 1g

1-Bromo-2-phenoxybenzene, 95.0%, 10g

4-(2-Hydroxyphenyl)-2-(3-pyridyl)thiazole, 5g

5-Methyl-2-o-tolylamino-thiazole-4-carboxylic acid, 95.0%, 1g